Published in Pharm Res on December 09, 2011
Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers. AAPS J (2015) 0.85
Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks. AAPS PharmSciTech (2014) 0.76
Evidence for the existence of powder sub-populations in micronized materials: aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties. Pharm Res (2014) 0.75
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate. AAPS PharmSciTech (2014) 0.75
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol (2013) 4.78
Abeta40 inhibits amyloid deposition in vivo. J Neurosci (2007) 2.47
Isolated gastrocnemius tightness. J Bone Joint Surg Am (2002) 1.93
The effects of age on medio-lateral stability during normal and narrow base walking. Gait Posture (2008) 1.42
Virtual Sensorimotor Training for Balance: Pilot Study Results for Children With Fetal Alcohol Spectrum Disorders. Pediatr Phys Ther (2016) 1.40
An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol (2012) 1.28
Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers. AAPS J (2012) 1.20
Pushrim biomechanics and injury prevention in spinal cord injury: recommendations based on CULP-SCI investigations. J Rehabil Res Dev (2005) 1.18
Effect of balance training on recovery of stability in children with cerebral palsy. Dev Med Child Neurol (2003) 1.18
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles. Nanotoxicology (2011) 1.17
Cell patterning: interaction of cardiac myocytes and fibroblasts in three-dimensional culture. Microsc Microanal (2008) 1.12
The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations. Pharm Res (2008) 1.10
Shoulder biomechanics during the push phase of wheelchair propulsion: a multisite study of persons with paraplegia. Arch Phys Med Rehabil (2008) 1.10
Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation. Pediatrics (2007) 1.07
Age-associated effects of a concurrent cognitive task on gait speed and stability during narrow-base walking. J Gerontol A Biol Sci Med Sci (2008) 1.04
Actin limits enhancement of nanoparticle diffusion through cystic fibrosis sputum by mucolytics. Pulm Pharmacol Ther (2006) 1.04
Phase I trial of preoperative hypofractionated intensity-modulated radiotherapy with incorporated boost and oral capecitabine in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2007) 1.03
The influence of dose on the performance of dry powder inhalation systems. Int J Pharm (2005) 1.01
Redefining the manual wheelchair stroke cycle: identification and impact of nonpropulsive pushrim contact. Arch Phys Med Rehabil (2009) 1.01
The cohesive-adhesive balances in dry powder inhaler formulations II: influence on fine particle delivery characteristics. Pharm Res (2004) 0.98
The cohesive-adhesive balances in dry powder inhaler formulations I: Direct quantification by atomic force microscopy. Pharm Res (2004) 0.96
An investigation into the dispersion mechanisms of ternary dry powder inhaler formulations by the quantification of interparticulate forces. Pharm Res (2007) 0.96
Age and features of movement influence motor overflow. J Am Geriatr Soc (2003) 0.93
The influence of fine excipient particles on the performance of carrier-based dry powder inhalation formulations. Pharm Res (2006) 0.92
An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances. Eur J Pharm Biopharm (2007) 0.92
Motor cortex activation is preserved in patients with chronic hemiplegic stroke. Ann Neurol (2002) 0.92
The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients. Mil Med (2010) 0.91
Effect of balance training on muscle activity used in recovery of stability in children with cerebral palsy: a pilot study. Dev Med Child Neurol (2005) 0.89
Target localization for post-prostatectomy patients using CT and ultrasound image guidance. J Appl Clin Med Phys (2005) 0.89
Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer. Int J Pharm (2013) 0.88
Multisite comparison of wheelchair propulsion kinetics in persons with paraplegia. J Rehabil Res Dev (2007) 0.88
Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol (2007) 0.87
Locomotor training using body-weight support on a treadmill in conjunction with ongoing physical therapy in a child with severe cerebellar ataxia. Phys Ther (2007) 0.86
Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation. Int J Pharm (2012) 0.86
The surface roughness of lactose particles can be modulated by wet-smoothing using a high-shear mixer. AAPS PharmSciTech (2004) 0.86
Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers. AAPS J (2015) 0.85
Sensory control of balance: a comparison of children with fetal alcohol spectrum disorders to children with typical development. J Popul Ther Clin Pharmacol (2013) 0.84
Dynamic vapor sorption properties of sodium starch glycolate disintegrants. Pharm Dev Technol (2005) 0.84
Health care providers' perspectives of an intervention designed to improve colorectal cancer screening rates in family medicine residency clinics : a qualitative study. J Cancer Educ (2012) 0.84
Cospray-dried unfractionated heparin with L-leucine as a dry powder inhaler mucolytic for cystic fibrosis therapy. J Pharm Sci (2008) 0.83
Particulate production during orthodontic production laboratory procedures. J Expo Sci Environ Epidemiol (2011) 0.83
Prostate bed motion during intensity-modulated radiotherapy treatment. Int J Radiat Oncol Biol Phys (2012) 0.83
Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J Pharm Sci (2006) 0.83
Factors affecting defining the quality and functionality of excipients used in the manufacture of dry powder inhaler products. Drug Dev Ind Pharm (2008) 0.82
Characterisation and functionality of inhalation anhydrous lactose. Int J Pharm (2010) 0.82
Dehydration of trehalose dihydrate at low relative humidity and ambient temperature. Int J Pharm (2006) 0.81
The effect of mechanical processing on surface stability of pharmaceutical powders: visualization by atomic force microscopy. J Pharm Sci (2003) 0.81
Particle synergy and aerosol performance in non-aqueous liquid of two combinations metered dose inhalation formulations: an AFM and Raman investigation. J Colloid Interface Sci (2011) 0.81
The influence of humidity on the aerosolisation of micronised and SEDS produced salbutamol sulphate. Eur J Pharm Sci (2004) 0.81
Effect of humidity on aerosolization of micronized drugs. Drug Dev Ind Pharm (2003) 0.81
An investigation into the effect of fine lactose particles on the fluidization behaviour and aerosolization performance of carrier-based dry powder inhaler formulations. AAPS PharmSciTech (2014) 0.80
Processing of spherical crystalline particles via a novel solution atomization and crystallization by sonication (SAXS) technique. Pharm Res (2004) 0.80
Continued investigation into the influence of loaded dose on the performance of dry powder inhalers: surface smoothing effects. Drug Dev Ind Pharm (2006) 0.80
Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. Eur J Pharm Sci (2004) 0.80
Novel temperature controlled surface dissolution of excipient particles for carrier based dry powder inhaler formulations. Drug Dev Ind Pharm (2006) 0.79
Engineering of crystalline combination inhalation particles of a long-acting beta2-agonist and a corticosteroid. Pharm Res (2009) 0.79
Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers. Ther Deliv (2013) 0.79
Under pressure: predicting pressurized metered dose inhaler interactions using the atomic force microscope. J Colloid Interface Sci (2003) 0.79
The role of force control agents in high-dose dry powder inhaler formulations. J Pharm Sci (2009) 0.78
Gait changes in response to subthalamic nucleus stimulation in people with Parkinson disease: a case series report. J Neurol Phys Ther (2006) 0.78
The use of colloid probe microscopy to predict aerosolization performance in dry powder inhalers: AFM and in vitro correlation. J Pharm Sci (2006) 0.78
Influence of crystal form of ipratropium bromide on micronisation and aerosolisation behaviour in dry powder inhaler formulations. J Pharm Pharmacol (2012) 0.78
Stamp test delivers message on erectile dysfunction after high-dose intensity-modulated radiotherapy for prostate cancer. Urology (2012) 0.78
Muscle responses to seated perturbations for typically developing infants and those at risk for motor delays. Dev Med Child Neurol (2004) 0.78
The influence of crystal habit on the prediction of dry powder inhalation formulation performance using the cohesive-adhesive force balance approach. Drug Dev Ind Pharm (2008) 0.77
Airborne particles produced during enamel cleanup after removal of orthodontic appliances. Am J Orthod Dentofacial Orthop (2003) 0.77
A novel apparatus for the determination of solubility in pressurized metered dose inhalers. Drug Dev Ind Pharm (2006) 0.77
Young Adults Largely Depend on Vision for Postural Control When Standing on a BOSU Ball but Not on Foam. J Strength Cond Res (2015) 0.76
Sustained local delivery of oncolytic short hairpin RNA adenoviruses for treatment of head and neck cancer. J Gene Med (2014) 0.76
The influence of relative humidity on the cohesion properties of micronized drugs used in inhalation therapy. J Pharm Sci (2004) 0.76
Hematopoietic derived cell infiltration of the intestinal tumor microenvironment in Apc Min/+ mice. Microsc Microanal (2011) 0.76
Defining the critical material attributes of lactose monohydrate in carrier based dry powder inhaler formulations using artificial neural networks. AAPS PharmSciTech (2014) 0.76
Investigation into the effect of humidity on drug-drug interactions using the atomic force microscope. J Pharm Sci (2003) 0.76
Addition of fluoroquinolone prophylaxis to a blood and marrow transplant unit reduces Gram-negative infections. Cancer Control (2005) 0.75
Objective Assessment of Joint Stiffness: A Clinically Oriented Hardware and Software Device with an Application to the Shoulder Joint. J Nov Physiother (2012) 0.75
The potential use of Raman mapping to investigate in vitro deposition of combination pressurized metered-dose inhalers. AAPS J (2004) 0.75
Advanced microscopy techniques to assess solid-state properties of inhalation medicines. Adv Drug Deliv Rev (2011) 0.75
The influence of secondary processing on the structural relaxation dynamics of fluticasone propionate. AAPS PharmSciTech (2014) 0.75
The development of a novel high-dose pressurized aerosol dry-powder device (PADD) for the delivery of pumactant for inhalation therapy. J Aerosol Med (2004) 0.75
Surface energy and interparticle forces correlations in model pMDI formulations. Pharm Res (2005) 0.75
The use of atomic force microscopy to study the conditioning of micronised budesonide. Int J Pharm (2008) 0.75
Growth spiral activity and step velocities on a crystal surface. Phys Rev Lett (2005) 0.75
Inhalation of aerosols produced during the removal of fixed orthodontic appliances: a comparison of 4 enamel cleanup methods. Am J Orthod Dentofacial Orthop (2008) 0.75
Effect of moisture on the compressibility and compactibility of sodium starch glycolate. Pharm Dev Technol (2007) 0.75
Interaction of moisture with sodium starch glycolate. Pharm Dev Technol (2007) 0.75
Dosimetry validation of treatment room shielding design. Med Phys (2005) 0.75